top of page


Clinical trials and basic clinical science research

In the past 35 years, MARC has been involved in over 300 pharmaceutical trials involving around 30 different pharmaceutical companies. We were involved in the first cholinesterase inhibitor and amyloid antibody trials. We have extensive experience in antibody and new generation anti-inflammatory agents.  MARC closely collaborates with the University of Southampton, with around 300 scientific papers in dementia research.

bottom of page